{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:35:29Z","timestamp":1793900129011,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970698"],"award-info":[{"award-number":["81970698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01659-7","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:34:32Z","timestamp":1780662872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Placebo response on the weight change and its influencing factors in overweight or obesity with or without diabetes: a meta-analysis of 182 anti-obesity medications trials"],"prefix":"10.1038","volume":"6","author":[{"given":"Yuchen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2365-9831","authenticated-orcid":false,"given":"Chu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-9455","authenticated-orcid":false,"given":"Zonglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-0543","authenticated-orcid":false,"given":"Xiaoling","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"1659_CR1","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/IJ9.0000000000000017","volume":"2","author":"M Agha","year":"2017","unstructured":"Agha, M. & Agha, R. The rising prevalence of obesity: part A: impact on public health. Int. J. Surg. Oncol. 2, e17 (2017).","journal-title":"Int. J. Surg. Oncol."},{"key":"1659_CR2","unstructured":"World Health Organisation. Obesity and overweight fact sheet. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/obesity-and-overweight (WHO, 2022)."},{"key":"1659_CR3","unstructured":"World Obesity Federation. World obesity atlas 2022. (London: World Obesity Federation) https:\/\/data.worldobesity.org\/publications\/?cat=15) (World Obesity Federation, 2022)."},{"key":"1659_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101850","volume":"57","author":"B Chong","year":"2023","unstructured":"Chong, B. et al. Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019. EClinicalMedicine 57, 101850 (2023).","journal-title":"EClinicalMedicine"},{"key":"1659_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/obr.12889","volume":"20","author":"T Semlitsch","year":"2019","unstructured":"Semlitsch, T., Stigler, F. L., Jeitler, K., Horvath, K. & Siebenhofer, A. Management of overweight and obesity in primary care-a systematic overview of international evidence-based guidelines. Obes. Rev. 20, 1218\u20131230 (2019).","journal-title":"Obes. Rev."},{"key":"1659_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ero.2025.09.006","volume":"1","author":"F Benedetti","year":"2025","unstructured":"Benedetti, F. The concept of placebo\/nocebo response and effect. EULAR Rheumatol. Open 1, 309\u2013311 (2025).","journal-title":"EULAR Rheumatol. Open"},{"key":"1659_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101685","volume":"54","author":"YH Chin","year":"2022","unstructured":"Chin, Y. H. et al. The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis. EClinicalMedicine 54, 101685 (2022).","journal-title":"EClinicalMedicine"},{"key":"1659_CR8","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372, n71 (2021).","journal-title":"Bmj"},{"key":"1659_CR9","unstructured":"James Thomas Julian Higgins. Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (The Cochrane Collaboration, 2023)."},{"key":"1659_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan, J. et al. PRESS peer review of electronic search strategies: 2015 guideline statement. J. Clin. Epidemiol. 75, 40\u201346 (2016).","journal-title":"J. Clin. Epidemiol."},{"key":"1659_CR11","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins, J. P. et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj 343, d5928 (2011).","journal-title":"Bmj"},{"key":"1659_CR12","unstructured":"Higgins, J. P., Li, T. & Deeks, J. J. Choosing effect measures and computing estimates of effect. in Cochrane Handbook for Systematic Reviews of Interventions, version 6.3. Cochrane (Higgins J., Thomas J., eds) www.training.cochrane.org\/handbook (2024)."},{"key":"1659_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev.psych.59.113006.095941","volume":"59","author":"DD Price","year":"2008","unstructured":"Price, D. D., Finniss, D. G. & Benedetti, F. A comprehensive review of the placebo effect: recent advances and current thought. Annu. Rev. Psychol. 59, 565\u2013590 (2008).","journal-title":"Annu. Rev. Psychol."},{"key":"1659_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(00)04169-6","volume":"357","author":"Z Di Blasi","year":"2001","unstructured":"Di Blasi, Z., Harkness, E., Ernst, E., Georgiou, A. & Kleijnen, J. Influence of context effects on health outcomes: a systematic review. Lancet 357, 757\u2013762 (2001).","journal-title":"Lancet"},{"key":"1659_CR15","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1111\/dom.15077","volume":"25","author":"M Bl\u00fcher","year":"2023","unstructured":"Bl\u00fcher, M. et al. New insights into the treatment of obesity. Diab. Obes. Metab. 25, 2058\u20132072 (2023).","journal-title":"Diab. Obes. Metab."},{"key":"1659_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01787-4","volume":"18","author":"C Lin","year":"2020","unstructured":"Lin, C. et al. Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus. BMC Med. 18, 322 (2020).","journal-title":"BMC Med."},{"key":"1659_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/bcp.12925","volume":"82","author":"HM de Wit","year":"2016","unstructured":"de Wit, H. M., Te Groen, M., Rovers, M. M. & Tack, C. J. The placebo response of injectable GLP-1 receptor agonists vs. oral DPP-4 inhibitors and SGLT-2 inhibitors: a systematic review and meta-analysis. Br. J. Clin. Pharm. 82, 301\u2013314 (2016).","journal-title":"Br. J. Clin. Pharm."},{"key":"1659_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000365248","volume":"61","author":"K Weimer","year":"2015","unstructured":"Weimer, K., Colloca, L. & Enck, P. Age and sex as moderators of the placebo response \u2013 an evaluation of systematic reviews and meta-analyses across medicine. Gerontology 61, 97\u2013108 (2015).","journal-title":"Gerontology"},{"key":"1659_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-3-642-30726-3_6","volume":"214","author":"F Franconi","year":"2012","unstructured":"Franconi, F., Campesi, I., Occhioni, S., Antonini, P. & Murphy, M. F. Sex and gender in adverse drug events, addiction, and placebo. Handb. Exp. Pharm. 214, 107\u2013126 (2012).","journal-title":"Handb. Exp. Pharm."},{"key":"1659_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/PSY.0b013e3182080d73","volume":"73","author":"PM Aslaksen","year":"2011","unstructured":"Aslaksen, P. M., Bystad, M., Vambheim, S. M. & Flaten, M. A. Gender differences in placebo analgesia: event-related potentials and emotional modulation. Psychosom. Med. 73, 193\u2013199 (2011).","journal-title":"Psychosom. Med."},{"key":"1659_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1067\/mcp.2001.118366","volume":"70","author":"M Averbuch","year":"2001","unstructured":"Averbuch, M. & Katzper, M. Gender and the placebo analgesic effect in acute pain. Clin. Pharm. Ther. 70, 287\u2013291 (2001).","journal-title":"Clin. Pharm. Ther."},{"key":"1659_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0304-3959(98)00088-8","volume":"77","author":"ME Robinson","year":"1998","unstructured":"Robinson, M. E., Riley, J. L. 3rd, Brown, F. F. & Gremillion, H. Sex differences in response to cutaneous anesthesia: a double blind randomized study. Pain 77, 143\u2013149 (1998).","journal-title":"Pain"},{"key":"1659_CR23","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2004.01.024","volume":"126","author":"C Su","year":"2004","unstructured":"Su, C., Lichtenstein, G. R., Krok, K., Brensinger, C. M. & Lewis, J. D. A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn\u2019s disease. Gastroenterology 126, 1257\u20131269 (2004).","journal-title":"Gastroenterology"},{"key":"1659_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01587-0","volume":"24","author":"SJ Tepper","year":"2023","unstructured":"Tepper, S. J. et al. The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression. J. Headache Pain. 24, 54 (2023).","journal-title":"J. Headache Pain."},{"key":"1659_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ecco-jcc\/jjw004","volume":"10","author":"V Jairath","year":"2016","unstructured":"Jairath, V. et al. Systematic review and meta-analysis: placebo rates in induction and maintenance trials of ulcerative colitis. J. Crohns Colitis 10, 607\u2013618 (2016).","journal-title":"J. Crohns Colitis"},{"key":"1659_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40261-018-0661-1","volume":"38","author":"A Matsusaki","year":"2018","unstructured":"Matsusaki, A., Kaneko, M. & Narukawa, M. Meta-analysis of placebo response in randomized clinical trials of antipsychotic drugs using PANSS focusing on different approaches to the handling of missing data. Clin. Drug Investig. 38, 751\u2013761 (2018).","journal-title":"Clin. Drug Investig."},{"key":"1659_CR27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1176\/appi.ajp.2013.12030315","volume":"170","author":"O Agid","year":"2013","unstructured":"Agid, O. et al. Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010. Am. J. Psychiatry 170, 1335\u20131344 (2013).","journal-title":"Am. J. Psychiatry"},{"key":"1659_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.schres.2018.05.009","volume":"201","author":"S Leucht","year":"2018","unstructured":"Leucht, S. et al. 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response. Schizophr. Res. 201, 315\u2013323 (2018).","journal-title":"Schizophr. Res."},{"key":"1659_CR29","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1097\/j.pain.0000000000000333","volume":"156","author":"AH Tuttle","year":"2015","unstructured":"Tuttle, A. H. et al. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain 156, 2616\u20132626 (2015).","journal-title":"Pain"},{"key":"1659_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pnpbp.2017.10.016","volume":"81","author":"LB Razza","year":"2018","unstructured":"Razza, L. B. et al. A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials. Prog. Neuropsychopharmacol. Biol. Psychiatry 81, 105\u2013113 (2018).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1659_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1210\/endrev\/bnab034","volume":"43","author":"AM Angelidi","year":"2022","unstructured":"Angelidi, A. M., Belanger, M. J., Kokkinos, A., Koliaki, C. C. & Mantzoros, C. S. Novel noninvasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy. Endocr. Rev. 43, 507\u2013557 (2022).","journal-title":"Endocr. Rev."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01659-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:16:44Z","timestamp":1787375804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01659-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1659"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01659-7","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Linong Ji has received fees for lecture presentations and for consulting from AstraZeneca, Merck, Metabasis, MSD, Novartis, Eli Lilly, Roche, Sanofi-Aventis, and Takeda. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"454"}}